Your MG Patients' Top QuestionsMyasthenia gravis (MG) presents a unique set of challenges for patients. As healthcare providers (HCPs), understanding their most pressing concerns is paramount to delivering comprehensive and empathetic care.
The Road to Individualized MG TreatmentMyasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder characterized by muscle weakness and fatigue...
Differential Diagnosis: Ruling Out MimickersWhile the hallmark symptoms of myasthenia gravis (MG) are fatigue and weakness, often affecting ocular, bulbar, facial, and limb muscles...
Assessing MG Patients’ Meningococcal Vaccine StatusA comprehensive assessment of meningococcal vaccine status is paramount in MG patients. Ideally, vaccine status should be confirmed at the time of diagnosis and carefully considered in the context of planned or ongoing immunosuppressive treatments.
Hear+Now: An AI-Powered Audio Digest - Vaccinations for MG PatientsOur latest AI audio digest features a concise discussion on the immunological considerations and clinical recommendations surrounding vaccination in MG, emphasizing key vaccines and optimal timing to bolster patient immunity while mitigating potential risks.
What Do Improvements on the MG-ADL Scale Mean for Patients?Key Takeaways:For healthcare providers (HCPs) treating patients with myasthenia gravis (MG), understanding the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale is fundamental. It helps HCPs assess how the disease...
Targeted Symptom Management StrategiesWhile anti-cholinesterase inhibitors (AChEs) like pyridostigmine (Mestinon®) are often the first-line treatment for managing symptoms of myasthenia gravis...
Managing MG in Special PopulationsMG can affect people of any age. But its presentation, diagnosis, and management pose unique challenges in special populations, namely children, pregnant people, and the elderly.
Clinical Knowledge Assessment: MG Diagnostic & Therapeutic ChallengesChallenge your Myasthenia Gravis understanding. Take this clinical quiz for clinicians covering MG patient presentations, diagnostic pathways, and treatment considerations.
Actively Recruiting MG Clinical TrialsSeveral clinical trials are currently enrolling participants with generalized myasthenia gravis (gMG) and ocular myasthenia gravis (OMG), exploring various mechanisms of action...
Vaccinations and MG: Current RecommendationsVaccination is a critical aspect of healthcare for all individuals, and it holds particular importance for patients with myasthenia gravis (MG). Due to potential immunosuppression...
How to Identify Patients Whose gMG Symptoms Are Not Well-controlledKey Takeaways:Recognizing when generalized myasthenia gravis (gMG) symptoms are not well-controlled is vital for optimizing patient outcomes. While a range of treatments is available, achieving symptom control can be challenging...
Empowering Patients: The Quest for Information and Better Treatment in MGIn recent years, a significant shift has occurred in myasthenia gravis (MG) care, with patients increasingly taking an active, empowered role in managing their condition.
Patient Perspectives on Misunderstanding and Stigma in MGPeople living with myasthenia gravis (MG) frequently face unique challenges, particularly concerning misunderstanding and stigma.
